Optimization of placebo use in clinical trials with systemic treatments for atopic dermatitis: an International Eczema Council survey‐based position statement

por Leshem, Y.A., Bissonnette, R., Paul, C., Silverberg, J.I., Irvine, A.D., Paller, A.S., Cork, M.J., Guttman‐Yassky, E.
Publicado 2019

Psychometric validation and responder definition of the sleep disturbance numerical rating scale in moderate‐to‐severe atopic dermatitis

por Puelles, J., Fofana, F., Rodriguez, D., Silverberg, J.I., Wollenberg, A., Dias Barbosa, C., Vernon, M., Chavda, R., Gabriel, S., Piketty, C.
Publicado 2021

High threshold efficacy responses in moderate‐to‐severe atopic dermatitis are associated with additional quality of life benefits: pooled analyses of abrocitinib monotherapy studie...

por Ständer, S., Bhatia, N., Gooderham, M. J., Silverberg, J. I., Thyssen, J. P., Biswas, P., DiBonaventura, M., Romero, W., Farooqui, S. A.
Publicado 2022

Symptoms and diagnosis of anxiety and depression in atopic dermatitis in U.S. adults

por Silverberg, J.I., Gelfand, J.M., Margolis, D.J., Boguniewicz, M., Fonacier, L., Grayson, M.H., Ong, P.Y., Chiesa Fuxench, Z.C., Simpson, E.L.
Publicado 2019

Comparative efficacy and safety of systemic therapies used in moderate‐to‐severe atopic dermatitis: a systematic literature review and network meta‐analysis

por Silverberg, J.I., Thyssen, J.P., Fahrbach, K., Mickle, K., Cappelleri, J.C., Romero, W., Cameron, M.C., Myers, D.E., Clibborn, C., DiBonaventura, M.
Publicado 2021

Systematic review of atopic dermatitis disease definition in studies using routinely collected health data

por Dizon, M.P., Yu, A.M., Singh, R.K., Wan, J., Chren, M.‐M., Flohr, C., Silverberg, J.I., Margolis, D.J., Langan, S.M., Abuabara, K.
Publicado 2018

Patient perspectives of atopic dermatitis: comparative analysis of terminology in social media and scientific literature, identified by a systematic literature review

por Silverberg, J.I., Feldman, S.R., Smith Begolka, W., Johnson, M.B., Stanojev, C., DiBonaventura, M., Rojo Cella, R., Valdez, H., Feeney, C., Thyssen, J.P.
Publicado 2022

Dupilumab significantly improves sleep outcomes in adult patients with atopic dermatitis: results from five randomized clinical trials

por Beck, L.A., Silverberg, J.I., Simpson, E.L., Yosipovitch, G., Eckert, L., Guillemin, I., Chen, Z., Ardeleanu, M., Plaum, S., Graham, N., Ruddy, M., Pirozzi, G., Gadkari, A.
Publicado 2020

Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phas...

por Silverberg, J.I., Toth, D., Bieber, T., Alexis, A.F., Elewski, B.E., Pink, A.E., Hijnen, D., Jensen, T.N., Bang, B., Olsen, C.K., Kurbasic, A., Weidinger, S.
Publicado 2021

Impact of baricitinib in combination with topical steroids on atopic dermatitis symptoms, quality of life and functioning in adult patients with moderate‐to‐severe atopic dermatiti...

por Wollenberg, A., Nakahara, T., Maari, C., Peris, K., Lio, P., Augustin, M., Silverberg, J.I., Rueda, M.J., DeLozier, A.M., Pierce, E., Yang, F.E., Sun, L., Ball, S., Tauber, M., Paul, C.
Publicado 2021

Dupilumab provides important clinical benefits to patients with atopic dermatitis who do not achieve clear or almost clear skin according to the Investigator's Global Assessment: a...

por Silverberg, J.I., Simpson, E.L., Ardeleanu, M., Thaçi, D., Barbarot, S., Bagel, J., Chen, Z., Eckert, L., Chao, J., Korotzer, A., Rizova, E., Rossi, A.B., Lu, Y., Graham, N.M.H., Hultsch, T., Pirozzi, G., Akinlade, B.
Publicado 2019